July 29, 2025

Alvotech (ALVO) Investor Outlook: Exploring a Potential 78.39% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a healthcare innovator based in Luxembourg, is capturing investor attention with its robust pipeline of biosimilar products targeting significant therapeutic areas. Specializing in..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Key Insights on an 84.68% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the medical devices industry with its innovative solutions for diabetes management. Based in San Diego, California, Tandem..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: A Biotech with Promising Revenue Growth Amidst Volatility

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a burgeoning player in the biotechnology sector, is making waves with its innovative approach to treating rare diseases and cancer. Headquartered..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Potential 106% Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, is capturing investor attention with its promising potential for substantial returns. Operating primarily in the..

Disc Medicine, Inc. (IRON) Investor Outlook: A Promising 63.50% Potential Upside in Biotech

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors, riding on the wave of its innovative approach to tackling serious hematologic diseases. With a..

Ligand Pharmaceuticals Inc. (LGND) Stock Analysis: A Biotech Powerhouse with a 6.64% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with a promising portfolio of biopharmaceutical assets and a robust growth trajectory. With a..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A Healthcare Innovator with 40% Upside Potential

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is an intriguing player in the healthcare sector, particularly within the medical devices industry. Headquartered in San Jose, California, the company..

Recursion Pharmaceuticals (RXRX): Investor Outlook and Growth Potential in Biotech Innovation

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is carving out a unique niche within the biotechnology sector by leveraging cutting-edge technological innovations to transform the drug discovery process...

CONMED Corporation (CNMD) Stock Analysis: Exploring a 33% Potential Upside in the Medical Devices Sector

CONMED Corporation (CNMD), a prominent player in the healthcare sector specializing in medical devices, has caught the eye of investors with a potential upside of 33.15%..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Leveraging a Potential 26% Upside Amid Healthcare Tech Growth

GoodRx Holdings, Inc. (NASDAQ: GDRX) remains a compelling case for investors interested in the healthcare technology sector. With a market capitalization of approximately $1.79 billion, GoodRx..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape with a -22.70% Potential Downside

Galapagos NV (GLPG), a notable player in the biotechnology sector, is at a critical juncture. With a market cap of $2.16 billion and a current trading..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 133% Potential Upside in Tumor Treating Technologies

NovoCure Limited (NVCR), a Switzerland-based oncology company, is making headlines with its innovative Tumor Treating Fields (TTFields) devices. Operating within the healthcare sector and medical device..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Uncovering Potential 84.47% Upside in Behavioral Healthcare

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a leader in the behavioral healthcare sector, presents a compelling investment opportunity with its potential upside of 84.47%. Headquartered in..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring the 26.92% Potential Upside Amidst Revolutionary Gene Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP), a leader in the cutting-edge field of gene editing, is capturing investor attention with its pioneering CRISPR/Cas9 technology. This Switzerland-based biotechnology..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Report: Unlocking 16.73% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to take a closer look at Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the specialty..

Bausch Health Companies Inc. (BHC) Stock Analysis: A Potential Turnaround with an Attractive Forward P/E

Investors looking for opportunities in the healthcare sector might want to consider Bausch Health Companies Inc. (NYSE: BHC), a diversified specialty pharmaceutical and medical device company..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 63.7% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) is capturing investor attention with a compelling growth narrative and a notable potential upside of 63.7% based on analyst consensus. As..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Powerhouse with 46% Upside Potential

For investors with a keen eye on the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents an intriguing opportunity. Based in China, this biopharmaceutical company is..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 23% Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $2.42 billion, GeneDx..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the medical instruments and supplies industry, is attracting investor attention with its mix of challenges and potential. The..

Search

Funds

July 29, 2025

Search

Funds

July 29, 2025

FTSE 100

Funds